Pluvicto for Metastatic Castrate Resistant Prostate Cancer

UF Health MedEd Cast

English - July 29, 2022 05:00 - 10.8 MB
Health & Fitness health shands hospital clinical topics research Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Perioperative Optimization of the Elderly Spine Surgery Patients

Next Episode: Hypertrophic Cardiomyopathy Update

Robert Zlotecki M.D., PhD describes the factors that make a patient a candidate for Pluvicto treatment for prostate cancer. He explains the process of treatment through a series of Pluvicto infusions for prostate cancer and he outlines the current shift in thinking regarding systemic radiopharmaceutical therapy for prostate cancer.